Hao Zheng
Geschäftsführer bei Belief BioMed, Inc.
Profil
Hao Zheng is currently working as Vice President-Product Operations at Edding Group Co., Ltd.
and Senior Vice President-Operations at Belief BioMed, Inc. He completed his undergraduate degree from Tianjin University in 2006.
Aktive Positionen von Hao Zheng
| Unternehmen | Position | Beginn |
|---|---|---|
Edding Group Co., Ltd.
 Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 09.03.2019 |
Belief BioMed, Inc.
 Belief BioMed, Inc. BiotechnologyHealth Technology Belief BioMed, Inc. develops gene therapies. The Chinese company was founded in 2016 by Xiao Xiao and Jane Zheng. Jane Zheng has been the CEO since 2016. | Geschäftsführer | - |
Ausbildung von Hao Zheng
| Tianjin University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Edding Group Co., Ltd.
Edding Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Edding Group Co., Ltd. is an investment holding company that engages in the manufacture, research and development, and sale of pharmaceutical products. Its business segment includes manufacturing and distribution of pharmaceutical products, and research and development of new drugs. The company was founded by Xin Ni in September 2001 and is headquartered in Shanghai, China. | Commercial Services |
Belief BioMed, Inc.
Belief BioMed, Inc. BiotechnologyHealth Technology Belief BioMed, Inc. develops gene therapies. The Chinese company was founded in 2016 by Xiao Xiao and Jane Zheng. Jane Zheng has been the CEO since 2016. | Health Technology |
